BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4267735)

  • 1. Experimental study of rabbit fibrinogen degradation products. Influence of plasminogen level for the interpretation of serum concentration of fibrinogen degradation products in consumption coagulopathies.
    Soria J; Soria C; Vairel E; Prost RJ; Warneson G
    Thromb Diath Haemorrh; 1973 Feb; 29(1):115-21. PubMed ID: 4267735
    [No Abstract]   [Full Text] [Related]  

  • 2. [Measurement of fibrinogen degradation products: its usefulness in consumption coagulopathies].
    Thuot C; Perron L
    Union Med Can; 1973 Jan; 102(1):66-9. PubMed ID: 4706340
    [No Abstract]   [Full Text] [Related]  

  • 3. A functional plasminogen assay utilizing the potentiating effect of fibrinogen to correct for the overestimation of plasminogen in pathological plasma samples.
    Gram J; Jespersen J
    Thromb Haemost; 1985 Apr; 53(2):255-9. PubMed ID: 4024036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmin lysis of fibrinogen and fibrin and the antigenic properties of their degradation products.
    Ekert H; Muntz RH
    Br J Haematol; 1972 Jan; 22(1):103-10. PubMed ID: 4258329
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
    Thomas DP; Niewiarowski S; Myers AR; Bloch KJ; Colman RW
    N Engl J Med; 1970 Sep; 283(13):663-8. PubMed ID: 4247823
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of human and monkey (Macaca irus) fibrinogen degradation products.
    Poskitt TR; Fortwengler HP; Roth GJ; Eaton JA
    Thromb Diath Haemorrh; 1974 May; 31(2):319-27. PubMed ID: 4211751
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antisera to fibrinogen degradation products, fragments D and E].
    Sudo T; Fujisawa M; Okumura H; Manita H
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):652-3. PubMed ID: 4269798
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 10. Rocket immunoelectrophoresis for the rapid quantitation of plasma fibrinogen.
    Saoji AM; Jad CY; Kelkar SS
    Indian J Pathol Microbiol; 1984 Jan; 27(1):1-5. PubMed ID: 6511021
    [No Abstract]   [Full Text] [Related]  

  • 11. [The kidney and disseminated intravascular coagulation].
    Hisazumi H
    Rinsho Byori; 1985 Jun; Spec No 63():134-40. PubMed ID: 2931535
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinogen and its derivatives in intravascular coagulation. A review.
    Gerrits WB
    Neth J Med; 1975; 18(1):31-44. PubMed ID: 124019
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrinogen derivatives. A laboratory and clinical study.
    Vermylen J
    Verh K Vlaam Acad Geneeskd Belg; 1972; 34(2):125-208. PubMed ID: 4278099
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the standardization of fibrinolysis tests. II. Clinical significance of determination of fibrinolytic factors and its interpretation (author's transl)].
    Egawa H; Hashimoto S; Suzuki K
    Rinsho Byori; 1979 Mar; 27(3):250-6. PubMed ID: 155750
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic intravascular coagulation. Clinical spectrum and diagnostic criteria, with special emphasis on metabolism, distribution and localization of I 131 -fibrinogen.
    Straub PW
    Acta Med Scand Suppl; 1971; 526():1-95. PubMed ID: 5292077
    [No Abstract]   [Full Text] [Related]  

  • 17. An accelerated red-cell hemagglutination inhibition immunoassay for measuring fibrinogen degradation products in human serum.
    Fischer R; Furlan M; Beck EA
    Thromb Diath Haemorrh; 1971 Oct; 26(2):311-4. PubMed ID: 5167423
    [No Abstract]   [Full Text] [Related]  

  • 18. [Detection of serum fibrinogen degradation products using Merskey's technic, Apropos of 169 cases].
    KolodiƩ L; Seigneurin D; Micouin C; Hollard D
    Pathol Biol (Paris); 1974 Nov; 22 suppl():66-71. PubMed ID: 4219980
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnosis and therapy of consumption coagulopathy].
    Lechner K
    Wien Klin Wochenschr; 1973 Jun; 85(26):467-70. PubMed ID: 4268703
    [No Abstract]   [Full Text] [Related]  

  • 20. Disseminated intravascular coagulation in the early phase of experimental traumatic and haemorrhagic shock.
    Avikainen V; Eklund B
    Ann Chir Gynaecol Fenn; 1974; 63(3):217-25. PubMed ID: 4412844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.